Bharglob 16.5% Injection is used to strengthen the body's natural immune system to lower the risk of infection in persons with weakened immune system. It is made from healthy human blood that has a high level of certain defensive substances (antibodies), which help fight infections. Bharglob 16.5% Injection has been shown to be effective in preventing infections in bone marrow transplant patients more than 20 years of age in the first 100 days post-transplant. It is used in the treatment of patients where antibody-forming capacity is severely impaired thereby subjecting them to a greater risk of infections. Bharglob 16.5% Injection gives you antibodies that your body is not making on its own so you can fight infections. Both children and adults can have this therapy. It is administered as an injection. Your doctor will monitor you for some time after the administration of Bharglob 16.5% Injection to check for any side effects. Bharglob 16.5% Injection may sometimes cause side effects like jnjection site reactions such as swelling, redness, pain, induration, itching, bruising, and rash and flushing (sense of warmth in the face, ears, neck, and trunk), . If you get any of these, or other side effects, or just feel unwell, you should tell your doctor. There may be ways of preventing or reducing these effects.

Intaglob 16.5% Injection is used to strengthen the body's natural immune system to lower the risk of infection in persons with weakened immune system. It is made from healthy human blood that has a high level of certain defensive substances (antibodies), which help fight infections. Intaglob 16.5% Injection has been shown to be effective in preventing infections in bone marrow transplant patients more than 20 years of age in the first 100 days post-transplant. It is used in the treatment of patients where antibody-forming capacity is severely impaired thereby subjecting them to a greater risk of infections. Intaglob 16.5% Injection gives you antibodies that your body is not making on its own so you can fight infections. Both children and adults can have this therapy. It is administered as an injection. Your doctor will monitor you for some time after the administration of Intaglob 16.5% Injection to check for any side effects. Intaglob 16.5% Injection may sometimes cause side effects like jnjection site reactions such as swelling, redness, pain, induration, itching, bruising, and rash and flushing (sense of warmth in the face, ears, neck, and trunk), . If you get any of these, or other side effects, or just feel unwell, you should tell your doctor. There may be ways of preventing or reducing these effects.

Arpimune ME 50mg Capsule is used to prevent the body from rejecting a new organ after a liver, kidney, heart transplant, or bone marrow transplantation. It weakens the immune system so that your body does not attack the new organ. It is also used to treat nephrotic syndrome, severe rheumatoid arthritis, and psoriasis. The amount of Arpimune ME 50mg Capsule you take depends on your weight, medical condition, and what you are being treated for. Your doctor will plan the correct dose for you. Do not change the dose without talking to your doctor. It can be taken with or without food. It is better to take it, in the same way, and at the same time every day to get the maximum benefit. Keep taking it for as long as you have been told to, even if you feel well. Stopping treatment may increase the risk of your transplanted organ being rejected. The most common side effects of this medicine include headache, unusual growth of facial or body hair, high blood pressure, diarrhea, gingival hyperplasia, and tremors. Because it lowers your immune system, you may also catch more infections than usual. Tell your doctor straight away if you develop an infection. For the same reason, you may be more at risk of developing some cancers, particularly of the skin. You should limit your exposure to sunlight.

Arpimune-O 100mg Capsule is used to prevent the body from rejecting a new organ after a liver, kidney, heart transplant, or bone marrow transplantation. It weakens the immune system so that your body does not attack the new organ. It is also used to treat nephrotic syndrome, severe rheumatoid arthritis, and psoriasis. The amount of Arpimune-O 100mg Capsule you take depends on your weight, medical condition, and what you are being treated for. Your doctor will plan the correct dose for you. Do not change the dose without talking to your doctor. It can be taken with or without food. It is better to take it, in the same way, and at the same time every day to get the maximum benefit. Keep taking it for as long as you have been told to, even if you feel well. Stopping treatment may increase the risk of your transplanted organ being rejected. The most common side effects of this medicine include headache, unusual growth of facial or body hair, high blood pressure, diarrhea, gingival hyperplasia, and tremors. Because it lowers your immune system, you may also catch more infections than usual. Tell your doctor straight away if you develop an infection. For the same reason, you may be more at risk of developing some cancers, particularly of the skin. You should limit your exposure to sunlight.

Arpimune-O 50mg Capsule is used to prevent the body from rejecting a new organ after a liver, kidney, heart transplant, or bone marrow transplantation. It weakens the immune system so that your body does not attack the new organ. It is also used to treat nephrotic syndrome, severe rheumatoid arthritis, and psoriasis. The amount of Arpimune-O 50mg Capsule you take depends on your weight, medical condition, and what you are being treated for. Your doctor will plan the correct dose for you. Do not change the dose without talking to your doctor. It can be taken with or without food. It is better to take it, in the same way, and at the same time every day to get the maximum benefit. Keep taking it for as long as you have been told to, even if you feel well. Stopping treatment may increase the risk of your transplanted organ being rejected. The most common side effects of this medicine include headache, unusual growth of facial or body hair, high blood pressure, diarrhea, gingival hyperplasia, and tremors. Because it lowers your immune system, you may also catch more infections than usual. Tell your doctor straight away if you develop an infection. For the same reason, you may be more at risk of developing some cancers, particularly of the skin. You should limit your exposure to sunlight.

Bortesam 2mg Injection is a chemotherapy medication that belongs to the class of medicines called proteasome inhibitors. It consists of the active ingredient Bortezomib. It is indicated for the treatment of multiple myeloma and mantle cell lymphoma. Multiple myeloma refers to the cancerous progression of plasma cells that are predominant in the bone marrow. Mantle cell lymphoma is a less common cancer affecting the lymph nodes. This medication is concomitantly used with other chemotherapy medicines like pegylated liposomal doxorubicin, rituximab, cyclophosphamide, doxorubicin, dexamethasone, prednisolone or thalidomide for patients who have not started treatment and are ineligible for blood stem cell transplant. The common side effects likely associated with Bortesam 2mg Injection are Pneumonia, loss of appetite, sensitivity, tingling and burning sensation of the skin, nausea, vomiting, diarrhea, mouth ulcers, constipation, muscle and bone pain, hair loss, fever, infections, itching, redness, dehydration, stomach problems, etc., Inform your physician if these side effects disturb or persist in you.

Bortero 2mg Injection is a chemotherapy medication that belongs to the class of medicines called proteasome inhibitors. It consists of the active ingredient Bortezomib. It is indicated for the treatment of multiple myeloma and mantle cell lymphoma. Multiple myeloma refers to the cancerous progression of plasma cells that are predominant in the bone marrow. Mantle cell lymphoma is a less common cancer affecting the lymph nodes. This medication is concomitantly used with other chemotherapy medicines like pegylated liposomal doxorubicin, rituximab, cyclophosphamide, doxorubicin, dexamethasone, prednisolone or thalidomide for patients who have not started treatment and are ineligible for blood stem cell transplant. The common side effects likely associated with Bortero 2mg Injection are Pneumonia, loss of appetite, sensitivity, tingling and burning sensation of the skin, nausea, vomiting, diarrhea, mouth ulcers, constipation, muscle and bone pain, hair loss, fever, infections, itching, redness, dehydration, stomach problems, etc., Inform your physician if these side effects disturb or persist in you.

ALKACEL 50MG INJECTION belongs to a class of alkylating agents, also known as chemotherapeutic agents. It is used to treat various cancer conditions such as multiple myeloma ((a type of cancer that develops from cells in the bone marrow called plasma cells), advanced cancer of the ovaries, childhood neuroblastoma (cancer of the nervous system), malignant melanoma (skin cancer) and soft tissue sarcoma. Cancer is a genetic change in which the body's cells divide uncontrollably and spread into surrounding tissues. ALKACEL 50MG INJECTION is also used to destroy bone marrow and cancer cells in preparation for a bone marrow transplant in people with multiple myeloma. ALKACEL 50MG INJECTION contains Melphalan, which reduces the number of abnormal cells your body makes. Thus, it treats cancer efficiently. ALKACEL 50MG INJECTION will be administered only in a hospital setting by an experienced healthcare professional. The most common adverse reactions observed in patients treated with ALKACEL 50MG INJECTION are neutrophil count decreased, white blood cell count decreased, platelet count decreased, lymphocyte count decreased, diarrhoea, fatigue, anaemia, nausea, vomiting and hypokalemia. Most of these side effects do not require medical attention and will resolve gradually. However, you are advised to talk to your doctor if any of these side effects persist or worsen.

Religrast 300mcg injection contains the active constituent filgrastim. It is a white blood cell growth factor (granulocyte-colony stimulating factor) approved by the FDA to decrease the risk of developing febrile neutropenia (occurrence of fever or infection associated with low WBC count) and to reduce the duration of neutropenia (low white blood cell count) in people who have non-myeloid cancer and are receiving chemotherapy drugs. It is also used to increase the number of WBCs and decrease the length of time of fever in people with acute myeloid leukemia. It is also used in people undergoing bone marrow transplants and in people with severe chronic neutropenia (low number of neutrophils in the blood). Religrast 300mcg injection is also used to prepare the blood for leukapheresis (a treatment in which certain blood cells are removed from the blood). It is also indicated to increase the chance of survival in people exposed to harmful amounts of radiation, which can cause severe damage to the bone marrow. Other uses include in patients with advanced HIV infection, which will help to reduce the risk of infections.